Kiromic Biopharma
Martin D'Souza is a Scientific Advisor at Kiromic Biopharma. Martin was previously employed at Mercer University- Atlanta.
Martin J. D’Souza has a Ph.D. in Pharmaceutical Sciences from the University of Pittsburgh.
This person is not in the org chart
This person is not in any offices
Kiromic Biopharma
1 followers
Kiromic Biopharma is an immuno-oncology, target discovery, and gene editing company developing highly effective and safe tumor-specific cancer engineered immunotherapies to face and defeat multiple cancer types. They are focused on extending the benefits of immunotherapy by leveraging DIAMOND AI (Kiromic Diamond Artificial Intelligence), which is a multi-purpose computational platform that can identify new cancer immunological targets for T-Cells and B-Cells.